SciELO - Scientific Electronic Library Online

 
vol.41 issue5Adequancy of treatment with canaglifozin alter alerts pharmacovigilance in the health management areaCost-utility analysis of the fixed-dose combination of dolutegravir/abacavir/lamivudine as initial treatment of HIV+ patients in Spain author indexsubject indexarticles search
Home Pagealphabetic serial listing  

Services on Demand

Journal

Article

Indicators

Related links

  • On index processCited by Google
  • Have no similar articlesSimilars in SciELO
  • On index processSimilars in Google

Share


Farmacia Hospitalaria

On-line version ISSN 2171-8695Print version ISSN 1130-6343

Abstract

JUANBELTZ, Regina et al. Complementary medicine use in cancer patients receiving intravenous antineoplastic treatment. Farm Hosp. [online]. 2017, vol.41, n.5, pp.589-600. ISSN 2171-8695.  https://dx.doi.org/10.7399/fh.10805.

Objective:

Complementary and alternative medicine (CAM) use has grown considerably, although there is little research on the topic in Spain. The aim of this study was to determine the prevalence of complementary medicine use in adult cancer patients at the same time as they were receiving conventional treatment in a Spanish referral cancer centre.

Method:

An observational, descriptive, cross-sectional study was conducted in the Ambulatory Treatment Unit during 2 consecutive weeks in March 2015. Adult patients who were receiving intravenous chemotherapy were included. Study variables were obtained from a questionnaire and medical records.

Results:

316 patients were included. 32.3% of the patients reported complementary medicine use during this period and 89% were ingesting products by mouth, herbs and natural products being the most commonly used. 81% of patients started to use complementary medicine after diagnosis, and family/friends were the main source of information. 65% of the patients reported improvements, especially in their physical and psychological well-being. Significant predictors of CAM use were female gender (P=0.028), younger age (P<0.001), and secondary education (P=0.009).

Conclusions:

A large proportion of cancer patients receiving intravenous chemotherapy also use complementary medicine, which they mainly take by mouth. Due to the risk of chemotherapy-CAM interactions, it is important for health-professionals to keep abreast of research on this issue, in order to provide advice on its potential benefits and risks.

Keywords : Complementary therapies; Neoplasms; Antineoplastic agents; Medicinal plants; Homeopathy; Prevalence; Spain.

        · abstract in Spanish     · text in English | Spanish     · English ( pdf )